This NYSE American Profile Is Attempting To Make A Name In Multiple Billion Dollar Markets (Oversold Bounce Idea)
New Report Arrives 9:30AM EST Thursday
Sign Up To My SMS Update System - Directions Below
Shall we get to it?
There's still a ton of time left in the week and I've been circling a biotech NYSE American profile that looks like it could be primed for a potential breakout.
Your full report arrives at 9:30AM EST tomorrow.
Here are the ins and outs.
This company is looking to put their stamp on multiple addressable markets that have previously tallied or are expected to tally over $100Bn a piece in retail value.
Becoming a disruptor in these multiple markets could make this company a household name in the years to come.
To top it off, I want to give you 3 potential catalysts that could provide this company with a possible breakout spark in the near term.
Here are the key details:
Top 3 Potential Catalysts For This NYSE American Profile
#1. This profile has an analyst price target that is providing over 90% potential upside from Tuesday's closing valuation. On top of that, the profile is also displaying over 60% potential upside to its 52-week high.
#2. With a 14-Day Raw Stochastic around 10% and a 14-Day Williams %R around 90% at close Tuesday, this NYSE American idea has multiple technicals leaning towards oversold.
Additionally, its 9-Day Relative Strength Index is below 30%.
Could a big bounce/healthy reversal be right around the corner?
#3. The company just recently announced a restructuring of an in-vestment that should provide them with an expansion of "green wave" franchise capabilities.
While you have time now, do this: